Natixis Advisors’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,811
| Closed | -$1.1M | – | 1571 |
|
|
2023
Q3 | $1.1M | Buy |
+12,811
| New | +$1.1M | ﹤0.01% | 1152 |
|
|
2020
Q4 | – | Sell |
-13,533
| Closed | -$1.08M | – | 1247 |
|
|
2020
Q3 | $1.08M | Sell |
13,533
-1,885
| -12% | -$151K | 0.01% | 935 |
|
|
2020
Q2 | $1.37M | Buy |
15,418
+3,727
| +32% | +$330K | 0.01% | 896 |
|
|
2020
Q1 | $1.1M | Sell |
11,691
-672
| -5% | -$63.2K | 0.01% | 882 |
|
|
2019
Q4 | $1.33M | Sell |
12,363
-196
| -2% | -$21.1K | 0.01% | 921 |
|
|
2019
Q3 | $1.2M | Sell |
12,559
-3,320
| -21% | -$318K | 0.01% | 892 |
|
|
2019
Q2 | $1.52M | Sell |
15,879
-605
| -4% | -$57.9K | 0.01% | 843 |
|
|
2019
Q1 | $1.46M | Buy |
16,484
+1,649
| +11% | +$146K | 0.01% | 844 |
|
|
2018
Q4 | $1.23M | Sell |
14,835
-2,245
| -13% | -$186K | 0.01% | 854 |
|
|
2018
Q3 | $1.61M | Buy |
+17,080
| New | +$1.61M | 0.01% | 830 |
|
|
2015
Q1 | – | Sell |
-11,412
| Closed | -$685K | – | 1053 |
|
|
2014
Q4 | $685K | Sell |
11,412
-516
| -4% | -$31K | 0.01% | 869 |
|
|
2014
Q3 | $582K | Buy |
11,928
+704
| +6% | +$34.4K | 0.01% | 884 |
|
|
2014
Q2 | $577K | Buy |
11,224
+3,294
| +42% | +$169K | 0.01% | 973 |
|
|
2014
Q1 | $459K | Buy |
+7,930
| New | +$459K | 0.01% | 965 |
|